Elderly patients diagnosed with idiopathic pulmonary arterial hypertension: Results from the COMPERA registry

International Journal of Cardiology

Volumn 168, Issue 2, 2013, Pages 871-880

  Hoeper, Marius M ^a   Huscher, Doerte ^b   Ghofrani, H Ardeschir ^c   Delcroix, Marion ^d   Distler, Oliver ^e   Schweiger, Christian ^f   Grunig, Ekkehard ^g   Staehler, Gerd ^h   Rosenkranz, Stephan ⁱ   Halank, Michael ^j   Held, Matthias ^k   Grohé, Christian ^l   Lange, Tobias J ^m   Behr, Juergen ⁿ   Klose, Hans ^o   Wilkens, Heinrike ^p   Filusch, Arthur ^q   Germann, Martin ^r   Ewert, Ralf ^s   Seyfarth, Hans Juergen ^t   Olsson, Karen M ^a   Opitz, Christian F ^u   Gaine, Sean P ^v   Vizza, C Dario ^w   Vonk Noordegraaf, Anton ^x   Kaemmerer, Harald ^y   Gibbs, J Simon R ^z   Pittrow, David ^aa   more..

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c JUSTUS LIEBIG UNIVERSITY GIESSEN   (Germany)

^d UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^e UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^f UNIVERSITY OF DUISBURG ESSEN   (Germany)

^g UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^h Medical Clinic i   (Germany)

ⁱ UNIVERSITY OF COLOGNE   (Germany)

^j UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

^k Medical Mission Hospital   (Germany)

^l Department of Respiratory Medicine   (Germany)

^m UNIVERSITY HOSPITAL REGENSBURG   (Germany)

ⁿ RUHR UNIVERSITY BOCHUM   (Germany)

^o UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^p SAARLAND UNIVERSITY   (Germany)

^q UNIVERSITY OF HEIDELBERG   (Germany)

^r UNIVERSITY OF FREIBURG   (Germany)

^s UNIVERSITY OF GREIFSWALD   (Germany)

^t UNIVERSITY OF LEIPZIG   (Germany)

^u German Red Cross Hospital   (Germany)

^v MATER MISERICORDIAE UNIVERSITY HOSPITAL   (Ireland)

^w SAPIENZA UNIVERSITY OF ROME   (Italy)

^x VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^y TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^z NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^aa DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

more..

Author keywords

Elderly; Hemodynamics; Hypertension; Pulmonary; Survival

Indexed keywords

AMBRISENTAN; ANTICOAGULANT AGENT; BOSENTAN; CALCIUM CHANNEL BLOCKING AGENT; ENDOTHELIN RECEPTOR ANTAGONIST; ILOPROST; PHOSPHODIESTERASE V INHIBITOR; PROSTACYCLIN; PROSTACYCLIN DERIVATIVE; SILDENAFIL; SITAXSENTAN; TADALAFIL; TREPROSTINIL;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CONTROLLED STUDY; DISEASE REGISTRY; DRUG WITHDRAWAL; EUROPE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PULMONARY HYPERTENSION; SURVIVAL RATE; UNSPECIFIED SIDE EFFECT; WALKING;

ELDERLY; HEMODYNAMICS; HYPERTENSION; PULMONARY; SURVIVAL;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; HYPERTENSION, PULMONARY; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; REGISTRIES; SURVIVAL RATE;

EID: 84885316129     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2012.10.026     Document Type: Article

References (30)

1. Galie N, Hoeper MM, Humbert M, et al. Guidelines for the diagnosis and treatment of pulmonary hypertension. The task force for the diagnosis and treatment of pulmonary hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT). Eur Respir J 2009;34:1219-63.
2. Galie N, Hoeper MM, Humbert M, et al. Guidelines for the diagnosis and treatment of pulmonary hypertension: the task force for the diagnosis and treatment of pulmonary hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT). Eur Heart J 2009;30:2493-537.
3. Simonneau G, Robbins IM, Beghetti M, et al. Updated clinical classification of pulmonary hypertension. J Am Coll Cardiol 2009;54:S43-54.
4. Humbert M, Sitbon O, Chaouat A, et al. Pulmonary arterial hypertension in France: results from a national registry. Am J Respir Crit Care Med 2006;173: 1023-30.
5. Peacock AJ, Murphy NF, McMurray JJ, Caballero L, Stewart S. An epidemiological study of pulmonary arterial hypertension. Eur Respir J 2007;30:104-9.
6. Rich S, Dantzker DR, Ayres SM, et al. Primary pulmonary hypertension. A national prospective study. Ann Intern Med 1987;107:216-23.
7. D'Alonzo GE, Barst RJ, Ayres SM, et al. Survival in patients with primary pulmonary hypertension. Results from a national prospective registry. Ann Intern Med 1991;115:343-9.
8. Galie N,Manes A,Negro L, Palazzini M, Bacchi-ReggianiML, Branzi A.Ameta-analysis of randomized controlled trials in pulmonary arterial hypertension. Eur Heart J 2009;30:394-403.
9. Galie N, Brundage BH, Ghofrani HA, et al. Tadalafil therapy for pulmonary arterial hypertension. Circulation 2009;119:2894-903.
10. Foley RJ, Wilcox D, Walsh SJ, Azrin M, Hager WD. Survival of geriatric idiopathic pulmonary arterial hypertension patients. Conn Med 2011;75:11-5.
11. Frost AE, Badesch DB, Barst RJ, et al. The changing picture of patients with pulmonary arterial hypertension in the United States: how REVEAL differs from historic and non-US Contemporary Registries. Chest 2011;139:128-37.
12. Badesch DB, Raskob GE, Elliott CG, et al. Pulmonary arterial hypertension: baseline characteristics from the REVEAL registry. Chest 2010;137:376-87.
13. Pittrow D, Vonk Noordegraaf A, Vachiery JL, et al. International, prospective registry for the documentation of first-line and maintenance therapy in patients with pulmonary hypertension (CompERA-XL): aims, design, methods, and baseline characteristics of patients. Am J Resp Crit Care Med 2010;181:A4806.
14. Leuchte HH, Holzapfel M, Baumgartner RA, Neurohr C, Vogeser M, Behr J. Characterization of brain natriuretic peptide in long-term follow-up of pulmonary arterial hypertension. Chest 2005;128:2368-74.
15. van der Zander K, Houben AJ, Webb DJ, et al. Selective endothelin B receptor blockade does not influence BNP-induced natriuresis in man. Kidney Int 2006;69: 864-8.
16. Minai OA, Arroliga AC. Long-term results after addition of sildenafil in idiopathic PAH patients on bosentan. South Med J 2006;99:880-3.
17. Koch R. Schätzung und Vergleich von relativen Überlebensraten in der Langzeitbeobachtung Klinischer Krebsregister. Jahresbericht 2004/2005 des Tumorzentrums Dresden e.V., Dresden, 143-152.
18. Thenappan T, Shah SJ, Rich S, Gomberg-Maitland M. A USA-based registry for pulmonary arterial hypertension: 1982-2006. Eur Respir J 2007;30:1103-10.
19. Usui S, Yao A,HatanoM, et al. Upregulated neurohumoral factors are associatedwith left ventricular remodeling and poor prognosis in rats with monocrotaline-induced pulmonary arterial hypertension. Circ J 2006;70:1208-15.
20. Hoeper MM, Barbera JA, Channick RN, et al. Diagnosis, assessment, and treatment of non-pulmonary arterial hypertension pulmonary hypertension. J Am Coll Cardiol 2009;54:S85-96.
21. Humbert M, Sitbon O, Chaouat A, et al. Survival in patients with idiopathic, familial, and anorexigen-associated pulmonary arterial hypertension in the modern management era. Circulation 2010;122:156-63.
22. Rosenzweig EB, Morse JH, Knowles JA, et al. Clinical implications of determining BMPR2 mutation status in a large cohort of children and adults with pulmonary arterial hypertension. J Heart Lung Transplant 2008;27:668-74.
23. Rubin LJ, Badesch DB, Barst RJ, et al. Bosentan therapy for pulmonary arterial hypertension. N Engl J Med 2002;346:896-903.
24. Galie N, Olschewski H, Oudiz RJ, et al. Ambrisentan for the treatment of pulmonary arterial hypertension: results of the ambrisentan in pulmonary arterial hypertension, randomized, double-blind, placebo-controlled, multicenter, efficacy (ARIES) study 1 and 2. Circulation 2008;117:3010-9.
25. Humbert M, Sitbon O, Yaici A, et al. Survival in incident and prevalent cohorts of patients with pulmonary arterial hypertension. Eur Respir J 2010;36:549-55.
26. Thenappan T, Shah SJ, Rich S, Tian L, Archer SL, Gomberg-Maitland M. Survival in pulmonary arterial hypertension: a reappraisal of the NIH risk stratification equation. Eur Respir J 2010;35:1079-87.
27. Jing ZC, Xu XQ, Han ZY, et al. Registry and survival study in chinese patients with idiopathic and familial pulmonary arterial hypertension. Chest 2007;132:373-9.
28. Gitt AK, Bueno H, Danchin N, et al. The role of cardiac registries in evidence-based medicine. Eur Heart J 2010;31:525-9.
29. Epstein M. Guidelines for good pharmacoepidemiology practices (GPP). Pharmacoepidemiol Drug Saf 2005;14:589-95.
30. McLaughlin VV, Archer SL, Badesch DB, et al. ACCF/AHA 2009 expert consensus document on pulmonary hypertension: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association: developed in collaboration with the American College of Chest Physicians, American Thoracic Society, Inc., and the Pulmonary Hypertension Association. Circulation 2009;119:2250-94.